Role of signal transducer and activator of transcription 5 in nucleophosmin/anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells

Cancer Research

Volumn 61, Issue 17, 2001, Pages 6517-6523

  Nieborowska Skorska, Malgorzata ^a   Slupianek, Artur ^a   Xue, Liquan ^b   Zhang, Qian ^c   Raghunath, Puthiyaveettil N ^c   Hoser, Grazyna ^d   Wasik, Mariusz A ^c   Morris, Stephan W ^b   Skorski, Tomasz ^a  

^a Temple University   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; BETA CASEIN; GENE PRODUCT; NUCLEOPHOSMIN; PROTEIN TYROSINE KINASE; STAT5 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; CLONOGENESIS; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; FUSION GENE; GENE DELETION; LYMPHOID CELL; LYMPHOMA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RETROVIRUS; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; FEMALE; GROWTH SUBSTANCES; HUMANS; LYMPHOCYTES; LYMPHOMA; MICE; MICE, INBRED BALB C; MICE, SCID; MILK PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION;

EID: 0035419348     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Protein tyrosine kinases and cancer
2. Chromosome aberrations and cancer
3. Fused transcript of ab1 and bcr genes in chronic myelogenous leukaemia
4. Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL)
5. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
6. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
7. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
8. Fusion of a kinase gene. ALK, to a nucleolar protein gene NPM in non-Hodgkin’s lymphoma
9. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas
10. CD30(+) anaplastic large cell lymphoma: A review of its histopathologic, genetic, and clinical features
11. Major nucleolar proteins shuttle between nucleus and cytoplasm
12. Molecular characterization of ALK a receptor tyrosine kinase expressed specifically in the nervous system
13. ALK, the chromosome 2 gene locus altered by the t(2:5) in non-Hodgkin’s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)
14. Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice
15. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-I lymphoma cell line with chromosomal transiocation t(2;5)
16. Role of the nucleophosmin (NPM) portion of the non-Hodgkin’s lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis
17. Nucleophosminanaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity
18. Differential complementation of Bcr-Ab1 point mutants with c-Myc
19. Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway
20. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
21. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
22. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis
23. The state of the STATs: Recent developments in the study of signal transduction to the nucleus
24. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
25. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
26. Stat5a is mandatory for adult mammary gland development and lactogenesis
27. Carboxyl-truncated STAT5β is generated by a nucleus-associated serine protease in early hematopoietic progenitors
28. Regulation of cell growth by IL-2: Role of STAT5 in protection from apoptosis but not in cell cycle progression
29. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation
30. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation
31. Transcriptional regulation of the cyclin DI promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
32. Activation of Jag/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome
33. STAT- related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients
34. STAT5 activation by BCR-Ab1 contributes to transformation of K562 leukemia cells
35. Blockade of the Bcr-Ab1 kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL
36. STAT5 activation contributes to growth and viability in Bcr/Ab1-transformed cells
37. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus
38. The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: Role in adhesion, invasion, and homing
39. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis
40. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line
41. Al, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation
42. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: A direct role for Stat5 in Bcl-X(L) induction
43. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related
44. Mouse oncostatin M: An immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway
45. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice
46. Accelerated neutrophil apoptosis in mice lacking AI-a, a subtype of the bcl-2-related Al gene
47. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity
48. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway
49. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors
50. Oncostatin M: Signal transduction and biological activity
51. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5
52. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2
53. Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions
54. bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple hemopoietic neoplasms in mice
55. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells